4//SEC Filing
TREACE JOHN R 4
Accession 0000899243-21-017470
CIK 0001630627other
Filed
Apr 28, 8:00 PM ET
Accepted
Apr 29, 9:13 PM ET
Size
13.6 KB
Accession
0000899243-21-017470
Insider Transaction Report
Form 4
TREACE JOHN R
Director
Transactions
- Conversion
Common Stock
2021-04-27+427,875→ 2,707,856 total(indirect: John R. Treace and Ginger D. Treace JTTEN) - Sale
Common Stock
2021-04-27$17.00/sh−401,250$6,821,250→ 2,306,606 total(indirect: John R. Treace and Ginger D. Treace JTTEN) - Other
Series A Preferred Stock
2021-04-27+9,906→ 9,906 total(indirect: John R. Treace and Ginger D. Treace JTTEN)→ Common Stock (9,906 underlying) - Conversion
Series A Preferred Stock
2021-04-27−427,875→ 0 total(indirect: John R. Treace and Ginger D. Treace JTTEN)→ Common Stock (427,875 underlying)
Holdings
- 535,000(indirect: By Trust)
Common Stock
- 568,437(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date.
- [F2]These shares were sold by the Reporting Person as a selling stockholder in conjuction with the Issuer's Form S-1 filing, Registration Number 333-254863. The offering closed on April 27, 2021. The reported sale price reflects the price at which the Reporting Person sold shares to the underwriters.
- [F3]The Reporting Person disclaims beneficial ownership of shares held in trusts for which he is a co-trustee.
- [F4]The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend.
Documents
Issuer
TREACE MEDICAL CONCEPTS, INC.
CIK 0001630627
Entity typeother
Related Parties
1- filerCIK 0001185249
Filing Metadata
- Form type
- 4
- Filed
- Apr 28, 8:00 PM ET
- Accepted
- Apr 29, 9:13 PM ET
- Size
- 13.6 KB